Page last updated: 2024-11-04

sulfamonomethoxine and Carcinoma, Hepatocellular

sulfamonomethoxine has been researched along with Carcinoma, Hepatocellular in 1 studies

Sulfamonomethoxine: Long acting sulfonamide antibacterial agent.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Niu, Y1
Lin, Z1
Wan, A1
Sun, L1
Yan, S1
Liang, H1
Zhan, S1
Chen, D1
Bu, X1
Liu, P1
Chen, C1
He, W1
Lu, X1
Wan, G1

Other Studies

1 other study available for sulfamonomethoxine and Carcinoma, Hepatocellular

ArticleYear
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:3

    Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor;

2021